Psychological and neurocognitive assessment can provide empirical data that can be very valuable to the trier of fact in determining the presence, severity, and absence of psychological and neurocognitive damages in children and adolescents. Testing provided by psychologists who are highly trained and experienced with forensic assessment can be extremely helpful for plaintiff and defense […]
Dr. Choi digs into the psychopaths brain, literally. He examines how their brain reacts and thinks compared to an average brain, hoping that we do our part to guide the psychopaths to a better life.
We truly live in the golden age of neuroscience. Advances in technology over the past 20 years have given modern neuro-researchers tools of unprecedented power to probe the workings of the most complex machine in the universe (as far as we know).
Watch the FREE video recording of this webinar. Everything You Need to Know About Assessing PTSD Claims In Mass Tort Litigation: The “Team” Approach. Get up to speed on the medical and scientific aspects of PTSD in mass tort and multi-claimant cases. With Mark I. Levy, MD, DLFAPA and Sarah A. Hall, PhD.
Facebook can be great fun. How else would I have seen a video of an eight-year-old drummer-girl utterly thrashing Led Zeppelin’s Good Times Bad Times? Or a dog running away with a lit skyrocket as his human friends run, duck and ditch for their lives? Or what your cat looks like in a tuxedo?
As opioid addiction continues to claim lives and litigation continues to expand, attorneys who may have potential clients – as plaintiffs or defendants – will benefit from this 95-minute session with Dr. David Kan, who has been retained by plaintiffs in the opioid MDL in Ohio.
The Team Approach to Forensic Psychiatric Assessment in Mass Tort or Multi-Plaintiff Complex Litigation There are key advantages to employing a “Single Team Approach” to assessing emotional damages claims in a mass tort population. Whether part of a class action, consolidated individual claims, multi-district litigation, or another procedure, a large population of claimants seeking emotional […]
James A. Armontrout, MD, John Torous, MD, Marsha Cohen, JD, Dale E. McNiel, PhD, and Renée Binder, MD — The Journal of the American Academy of Psychiatry and the Law — In recent years, the availability of software that is targeted toward the general public and designed to assist in the diagnosis and treatment of […]
A passenger vehicle is rear-ended by a commercial vehicle traveling at 30 mph on a state road. The driver of the passenger vehicle is seat belted. The airbags deployed, and the vehicle suffered moderate rear end damage. Ambulance personnel note that the driver exited the vehicle without assistance, is awake, standing by the roadside and talking […]
By Forensic Psychiatrist Mark I Levy, MD, DLFAPA Mild Traumatic Brain Injury (“mTBI” or “concussion”) is a frequent claim in civil litigation where the plaintiff has sustained a head injury. The best evaluation of these claims is performed by a 3-part team of forensic neurologist, neuropsychologist and psychiatrist. The neurologist addresses and structural damage to […]
The cannabis landscape changed in 2016 with the passage of Proposition 64 in California, which legalized recreational use of cannabis and possession of less than an ounce, as Prop 215 legalized medicinal use in 1996. Dr. Kan noted that experience has shown that medicinal use of cannabis decreased opioid mortality among patients, dropping by 5% […]
Many attorneys, when working on a case in which the mental health status of one of the parties is a significant issue, consider relying solely on a treating psychiatrist to serve as an independent expert psychiatric witness. Engaging the treating psychiatrist may seem efficient, cost-effective, and simply seeking expertise from the professional who knows the individual […]
This is a slide show presentation and subsequent webinar presented to NARTC by David Kan, M.D., D.F.A.S.A.M., a Diplomate Am. Bd. Psychiatry & Neurology in Psychiatry, Forensic Psychiatry and Addiction Medicine, Associate Clinical Professor Psychiatry, UCSF School of Medicine, an original member of Forensic Psychiatric Associates Medical Corporation and current President of the California Society of Addiction Medicine. […]
1. Authentic PTSD can, and usually does, produce severe disability of a person’s psychological functioning: It is important to remember that “impairment of psychosocial functioning” is a sine qua non for every psychiatric diagnosis listed in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5 ). Thus, although genuine PTSD is usually severely disabling, in the absence of marked […]
Opioid addiction is taking a devastating toll on our families, friends, and neighbors across the country, but there is hope when patients can access effective treatment services. ASAM is honored today to offer its thoughts and expertise on how we can close the treatment gap, improve the quality of care, and ultimately save lives.
fpamed Forensic Psychiatrist and President of the California Society for Addiction Medicine, David Y. Kan, MD DFASAM, was quoted in this recent article published in California Healthline By Pauline Bartolone July 12, 2017 Dr. Mark Satterfield sees a patient in recovery from heroin addiction at the Plumas County public health offices. Local officials say Satterfield […]
The Opioid Crisis Continues to Grow by David Kan MD DFASAM (Distinguished Fellow of the American Society of Addiction Medicine) forensic psychiatrist, fpamed The opioid crisis continues to grow. Recent data from the Centers for Disease Control show that overdose death rates have risen in every ethnic group. The most recent CDC data show that […]
Bright Heart Health’s Medical Director, David Kan, MD, discusses the history of the opioid epidemic, opioid affects on the body, opioid treatment using medication, and more.
On January 25, 2017, Forensic Psychiatrist and Substance Abuse Expert, David Kan, MD,DFASAM, the current President-Elect of the California Society of Addiction Medicine, gave a national, interactive webinar to members of the National Association of Railroad Trial Counsel (NARTC) on the subject of Substance Use Disorders, focusing particularly on opioid abuse and its place in […]
Click here to download pdf of slide show accompanying Mark Levy MD’s 12-7-16 NARTC webinar on PTSD
Years ago, the distinguished and esteemed George Washington University forensic psychiatrist Robert I Simon MD, who sadly died earlier this year, wrote a wonderful monograph entitled “Two’s Company, Three’s a Crowd,” outlining the scientific and ethical problems posed by the presence of a third party during a forensic psychiatric examination. In 2003, a California Appellate […]
These are the slides accompanying a presentation on “PTSD” given by forensic psychiatrist Mark I Levy MD, DLFAPA to the Association of American Railroads Claims Meeting in Nashville, Tennessee on October 12, 2016. Click here to view
Psychiatric News Alert The Voice of the American Psychiatric Association and the Psychiatric Community Dementia Prevalence in United States Falls Between 2000 to 2012, Report Finds Between 2000 and 2012, the proportion of U.S. adults 65 and older with dementia decreased significantly, from 11.6% to 8.8%, reported a study published today in JAMA Internal Medicine. […]
Charles Saldanha, MD has been appointed Interim Chair of Psychiatry for Alameda Health System. In this role, he will be the physician leader for an integrated public health care system that includes psychiatric emergency, inpatient psychiatry, partial hospitalization, substance use services, ambulatory and inpatient consultation and liaison psychiatry, and mental health services in a skilled […]
CSAM Releases Results of Survey on Insurance Barriers to Medication-Assisted Treatment of Opioid Use Disorders. The California Society of Addiction Medicine (CSAM) conducted a statewide survey during the September 2016 to assess insurance barriers in California to the treatment of patients with opioid use disorders.